Androgen receptor antagonist
| Androgen receptor antagonist | |
|---|---|
| Term | Androgen receptor antagonist |
| Short definition | Androgen receptor antagonist (AN-droh-jen reh-SEP-ter an-TA-guh-nist) substance that prevents androgens (male sex hormones) from attaching to proteins called androgen receptors, which are found in normal prostate cells, some prostate cancer cells and cells in some other tissues. Preventing this binding blocks the action of these hormones in the body. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Androgen receptor antagonist - (pronounced) (AN-droh-jen reh-SEP-ter an-TA-guh-nist) substance that prevents androgens (male sex hormones) from attaching to proteins called androgen receptors, which are found in normal prostate cells, some prostate cancer cells and cells in some other tissues. Preventing this binding blocks the action of these hormones in the body. Treatment with androgen receptor antagonists can prevent the growth of prostate cancer cells. Examples of androgen receptor antagonists used to treat prostate cancer are apalutamide, bicalutamide, darolutamide, enzalutamide, flutamide, and nilutamide. Also called androgen receptor blockers and antiandrogen
External links
- Medical encyclopedia article on Androgen receptor antagonist
- Wikipedia's article - Androgen receptor antagonist
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski